|Day Low/High||83.41 / 84.24|
|52 Wk Low/High||61.55 / 85.99|
- Alinity™ s System will screen the U.S. blood and plasma supply faster and more efficiently while maintaining highest levels of accuracy
We may have a few more days to get the excitement really going, but, boy, the gloom from two days ago is surely gone after Wednesday's rally.
We look at Comcast, Abbott Labs and Cisco.
Jim discusses Apple, a Comcast upgrade, Abbott Labs, and Jerome Powell's testimony.
Jim Cramer says investors may be misreading the Fed and the moment, but he's got your game plan for earnings season.
Jim Cramer checks in on Starbucks, General Electric, AbbVie, Adaptive Biotechnologies, Vector Group, PBF Energy and more.
Amgen shares have rallied in recent years. Dividend growth names like Amgen remain attractive in a low-yield environment. Healthcare will likely continue in the headlines.
- Real-world data from Advocate Health Care and Abbott shows prioritizing nutrition care for home health patients helped keep them out of the hospital
Stocks log gains for week on Fed rate-cut hopes and possible easing of U.S. trade tensions with China.
ABBOTT PARK, Ill., June 19, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2019 financial results on Wednesday, July 17, 2019, before the market opens.
- Program focused on helping people affected by conflict in Marawi City, Philippines
- Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation
A quiet week offered a chance to get ready for volatility around the FOMC meeting and G-20 summit later this month.
ABBOTT PARK, Ill., June 14, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share.
- 45% of blood donations have historically come from people over 50 years old, but that number is declining1
- Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has a positive impact among adults with Type 2 Diabetes who use multiple injections of insulin daily
We'll trim shares of Comcast and use that to finance a purchase in Kohl's.
We think Abbott Labs is a terrific company, but the stock already has a big premium and that may limit the potential of future gains.
Ironically, some experts now see biotech as a safe haven as the sector remains unaffected by trade wars and other global headwinds.
Stocks falter on realization that trade war between U.S. and China is about more than soybeans.
- Late-breaking data for Abbott's investigational clip-based tricuspid heart valve repair system presented at EuroPCR
In this market of haves and have-nots, too many stocks are still languishing and sentiment is sour -- but we're still likely oversold enough to potentially rally this week.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.